Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains Worldwide

RNAi has been suggested for use in gene therapy of HIV/AIDS, but the main problem is that HIV-1 is highly variable and could escape attack from the small interfering RNAs (siRNAs) due to even single nucleotide substitutions in the potential targets. To exhaustively check the variability in selected...

Full description

Bibliographic Details
Main Authors: Olga V. Kretova, Daria M. Fedoseeva, Maria A. Gorbacheva, Natalya M. Gashnikova, Maria P. Gashnikova, Nataliya V. Melnikova, Vladimir R. Chechetkin, Yuri V. Kravatsky, Nickolai A. Tchurikov
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Molecular Therapy: Nucleic Acids
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253117302202
_version_ 1819042522151780352
author Olga V. Kretova
Daria M. Fedoseeva
Maria A. Gorbacheva
Natalya M. Gashnikova
Maria P. Gashnikova
Nataliya V. Melnikova
Vladimir R. Chechetkin
Yuri V. Kravatsky
Nickolai A. Tchurikov
author_facet Olga V. Kretova
Daria M. Fedoseeva
Maria A. Gorbacheva
Natalya M. Gashnikova
Maria P. Gashnikova
Nataliya V. Melnikova
Vladimir R. Chechetkin
Yuri V. Kravatsky
Nickolai A. Tchurikov
author_sort Olga V. Kretova
collection DOAJ
description RNAi has been suggested for use in gene therapy of HIV/AIDS, but the main problem is that HIV-1 is highly variable and could escape attack from the small interfering RNAs (siRNAs) due to even single nucleotide substitutions in the potential targets. To exhaustively check the variability in selected RNA targets of HIV-1, we used ultra-deep sequencing of six regions of HIV-1 from the plasma of two independent cohorts of patients from Russia. Six RNAi targets were found that are invariable in 82%–97% of viruses in both cohorts and are located inside the domains specifying reverse transcriptase (RT), integrase, vpu, gp120, and p17. The analysis of mutation frequencies and their characteristics inside the targets suggests a likely role for APOBEC3G (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G, A3G) in G-to-A mutations and a predominant effect of RT biases in the detected variability of the virus. The lowest frequency of mutations was detected in the central part of all six targets. We also discovered that the identical RNAi targets are present in many HIV-1 strains from many countries and from all continents. The data are important for both the understanding of the patterns of HIV-1 mutability and properties of RT and for the development of gene therapy approaches using RNAi for the treatment of HIV/AIDS. Keywords: HIV-1, RNAi targets, gene therapy, ultra-deep sequencing, conserved HIV-1 sequences
first_indexed 2024-12-21T09:42:13Z
format Article
id doaj.art-108faf74656441c38a4a0d298be93785
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-12-21T09:42:13Z
publishDate 2017-09-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-108faf74656441c38a4a0d298be937852022-12-21T19:08:26ZengElsevierMolecular Therapy: Nucleic Acids2162-25312017-09-018330344Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains WorldwideOlga V. Kretova0Daria M. Fedoseeva1Maria A. Gorbacheva2Natalya M. Gashnikova3Maria P. Gashnikova4Nataliya V. Melnikova5Vladimir R. Chechetkin6Yuri V. Kravatsky7Nickolai A. Tchurikov8Department of Epigenetic Mechanisms of Gene Expression Regulation, Engelhardt Institute of Molecular Biology, 119334 Moscow, RussiaDepartment of Epigenetic Mechanisms of Gene Expression Regulation, Engelhardt Institute of Molecular Biology, 119334 Moscow, RussiaDepartment of Epigenetic Mechanisms of Gene Expression Regulation, Engelhardt Institute of Molecular Biology, 119334 Moscow, RussiaDepartment of Retroviruses, State Research Center of Virology and Biotechnology Vector, 630559 Koltsovo, RussiaDepartment of Retroviruses, State Research Center of Virology and Biotechnology Vector, 630559 Koltsovo, RussiaLaboratory of Post-Genomic Research, Engelhardt Institute of Molecular Biology, 119334 Moscow, RussiaDepartment of Epigenetic Mechanisms of Gene Expression Regulation, Engelhardt Institute of Molecular Biology, 119334 Moscow, RussiaDepartment of Epigenetic Mechanisms of Gene Expression Regulation, Engelhardt Institute of Molecular Biology, 119334 Moscow, RussiaDepartment of Epigenetic Mechanisms of Gene Expression Regulation, Engelhardt Institute of Molecular Biology, 119334 Moscow, Russia; Corresponding author: Nickolai A. Tchurikov, Department of Epigenetic Mechanisms of Gene Expression Regulation, Engelhardt Institute of Molecular Biology, 119334 Moscow, Russia.RNAi has been suggested for use in gene therapy of HIV/AIDS, but the main problem is that HIV-1 is highly variable and could escape attack from the small interfering RNAs (siRNAs) due to even single nucleotide substitutions in the potential targets. To exhaustively check the variability in selected RNA targets of HIV-1, we used ultra-deep sequencing of six regions of HIV-1 from the plasma of two independent cohorts of patients from Russia. Six RNAi targets were found that are invariable in 82%–97% of viruses in both cohorts and are located inside the domains specifying reverse transcriptase (RT), integrase, vpu, gp120, and p17. The analysis of mutation frequencies and their characteristics inside the targets suggests a likely role for APOBEC3G (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G, A3G) in G-to-A mutations and a predominant effect of RT biases in the detected variability of the virus. The lowest frequency of mutations was detected in the central part of all six targets. We also discovered that the identical RNAi targets are present in many HIV-1 strains from many countries and from all continents. The data are important for both the understanding of the patterns of HIV-1 mutability and properties of RT and for the development of gene therapy approaches using RNAi for the treatment of HIV/AIDS. Keywords: HIV-1, RNAi targets, gene therapy, ultra-deep sequencing, conserved HIV-1 sequenceshttp://www.sciencedirect.com/science/article/pii/S2162253117302202
spellingShingle Olga V. Kretova
Daria M. Fedoseeva
Maria A. Gorbacheva
Natalya M. Gashnikova
Maria P. Gashnikova
Nataliya V. Melnikova
Vladimir R. Chechetkin
Yuri V. Kravatsky
Nickolai A. Tchurikov
Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains Worldwide
Molecular Therapy: Nucleic Acids
title Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains Worldwide
title_full Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains Worldwide
title_fullStr Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains Worldwide
title_full_unstemmed Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains Worldwide
title_short Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains Worldwide
title_sort six highly conserved targets of rnai revealed in hiv 1 infected patients from russia are also present in many hiv 1 strains worldwide
url http://www.sciencedirect.com/science/article/pii/S2162253117302202
work_keys_str_mv AT olgavkretova sixhighlyconservedtargetsofrnairevealedinhiv1infectedpatientsfromrussiaarealsopresentinmanyhiv1strainsworldwide
AT dariamfedoseeva sixhighlyconservedtargetsofrnairevealedinhiv1infectedpatientsfromrussiaarealsopresentinmanyhiv1strainsworldwide
AT mariaagorbacheva sixhighlyconservedtargetsofrnairevealedinhiv1infectedpatientsfromrussiaarealsopresentinmanyhiv1strainsworldwide
AT natalyamgashnikova sixhighlyconservedtargetsofrnairevealedinhiv1infectedpatientsfromrussiaarealsopresentinmanyhiv1strainsworldwide
AT mariapgashnikova sixhighlyconservedtargetsofrnairevealedinhiv1infectedpatientsfromrussiaarealsopresentinmanyhiv1strainsworldwide
AT nataliyavmelnikova sixhighlyconservedtargetsofrnairevealedinhiv1infectedpatientsfromrussiaarealsopresentinmanyhiv1strainsworldwide
AT vladimirrchechetkin sixhighlyconservedtargetsofrnairevealedinhiv1infectedpatientsfromrussiaarealsopresentinmanyhiv1strainsworldwide
AT yurivkravatsky sixhighlyconservedtargetsofrnairevealedinhiv1infectedpatientsfromrussiaarealsopresentinmanyhiv1strainsworldwide
AT nickolaiatchurikov sixhighlyconservedtargetsofrnairevealedinhiv1infectedpatientsfromrussiaarealsopresentinmanyhiv1strainsworldwide